click below
click below
Normal Size Small Size show me how
UBC Pharmacology1
Anti-cancer Drugs
| Drug name | Class | Method of Action |
|---|---|---|
| Cyclophosphamide | Alkylating Agent | Drug covalently adds alkyl groups to DNA > Crosslinks DNA, ring cleavage, abnormal base pairing > apoptosis |
| Cisplatin | Platinum Compound | Covalently binds to DNA > X-links > DNA Damage > Apoptosis |
| Carboplatin | Platinum Compound | Covalently binds to DNA > X-links > DNA Damage > Apoptosis |
| Methotrexate | Anti-metabolite, Folate Analogue | Inhibits dihydrofolate reductase > depletes cell of folate > blocks DNA synthesis > Cells arrest in S phase |
| 5-Fluorouracil | Anti-metabolite, Pyrimidine Analogues | Inhibits thymidylate synthase > blocks DNA synthesis > cells arrest in S phase |
| Thioguanine | Anti-metabolite, Purine Analogue | Guanine derivative that incorporates into DNA but structural difference inhibits replication and transcription. |
| Paclitaxel | Anti-mitotic Agent, Taxanes | Binds to microtubules and inihibits depolymerization step required for cell division > cells arrest in mitosis |
| Docetaxel | Anti-mitotic Agent, Taxanes | Binds to microtubules and inihibits depolymerization step required for cell division > cells arrest in mitosis |
| Vincristine | Anti-mitotic Agent, Vinca Alkaloids | Drug binds tubulin monomers and prevents tubulin polymerization needed for cell division > cells arrest in mitosis. |
| Vinblastine | Anti-mitotic Agent, Vinca Alkaloids | Drug binds tubulin monomers and prevents tubulin polymerization needed for cell division > cells arrest in mitosis. |
| Doxorubicin | Topoisomerase Inhibitor | Intercalates into DNA > Interferes with transcription > generates O2 Free radicals > DNA damage (strand breakage) |
| Topotecan | Topoisomerase Inhibitor | Interferes with transcription >> Growth arrest?? |
| Bleomycin | Antitumour Antibiotic | Binds DNA and Fe2+ > Generates free radicals > results in DNA damage |
| Tamoxifen | Anti-Estrogen Antagonist | Competes with estrogen for receptor binding |
| Anastrozole | Aromatase Inhibitor | Prevents estradiol synthesis |
| Letrozole | Aromatase Inhibitor | Prevents estradiol synthesis |
| Gosrelin | LHRH Analogue | Blocks testosterone production via the pituitary |
| Leuprolide | LHRH Analogue | Blocks testosterone production via the pituitary |
| Flutamide | Anti-Androgen Antagonist | Competes with androgens for receptor binding |
| Cetuximab | Monoclonal antibody | MAb directed against extracellular portion of receptor - competitive inhibition of ligand binding, eg EGFR |
| Trastuzmab | Monoclonal antibody | MAb directed against extracellular portion of receptor - competitive inhibition of ligand binding, eg Her2 |
| Bevacizumab | Monoclonal antibody | MAb targetting the ligand, eg VEGF |
| Erlotinib | Tyrosine kinase inhibitor | cepetes with the ATP binding at the TK domain |
| IFN-alpha | Anti-angiogenic | blocks VEGF and bFGF gene transcription adn translation |
| Marimastat | Anti-angiogenic | Matrix metalloproteinase inhibitors which prevent the breakdown of the extracellular matrix. |
| Neovastat | Anti-angiogenic | Matrix metalloproteinase inhibitors which prevent the breakdown of the extracellular matrix. |